$BLLN News

BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference

Canaccord Genuity Initiates Coverage On BillionToOne with Buy Rating, Announces Price Target of $120

BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin

BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million

/C O R R E C T I O N -- BillionToOne/

Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions

BillionToOne Publishes NIPT Study Titled A Prospective, Multi-Site Study Of Performance Of Cell-Free DNA Testing For Recessive Conditions In A Large, General-Risk Pregnancy Population

BillionToOne, Inc. 2026 Q2 - Results - Earnings Call Presentation

BillionToOne (BLLN) Q2 2026 Earnings Call Transcript

BillionToOne: A Softer Quarter After Heightened Expectations

Can BillionToOne (BLLN) Justify Its Price On Earnings And Reaffirmed 2026 Guidance?

BillionToOne, Inc. Q2 2026 Earnings Call Summary

BTIG Maintains Buy on BillionToOne, Lowers Price Target to $130

BillionToOne Inc (BLLN) (Q2 2026) Earnings Call Highlights: Revenue Surges 64% as Oncology and ...

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move

BillionToOne (NASDAQ:BLLN) Shares Tumble After Q2 Profit Misses Estimates

BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say

Billiontoone Q2 Earnings Call Highlights

BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance

BillionToOne Affirms FY2026 Sales Guidance of $450.000M-$465.000M vs $456.440M Est